UroTech, Inc. an interventional medical device company
focused on minimally Invasive Surgical Procedures of the prostate,
targeted specifically at treating (BPH) Benign Prostatic Hyperplasia
which is estimated to effect over 15 million men within the United States.
Our Technology is on it's way!
The company is seeking funding from Accredited Investors to
accelerate the development of our BPH technology.
For more information regarding an Investment with UroTech, Inc.
Please contact us at Support@BPHTech.Com